Copyright Reports & Markets. All rights reserved.

Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 IgM (Immunoglobulin M) Test
    • 1.3.3 IgG (Immunoglobulin G) Test
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Clinic
    • 1.4.3 Hospital
    • 1.4.4 Laboratory
    • 1.4.5 Others
  • 1.5 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Size & Forecast
    • 1.5.1 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity (2021-2032)
    • 1.5.3 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Abcam plc
    • 2.1.1 Abcam plc Details
    • 2.1.2 Abcam plc Major Business
    • 2.1.3 Abcam plc Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.1.4 Abcam plc Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abcam plc Recent Developments/Updates
  • 2.2 QED Bioscience
    • 2.2.1 QED Bioscience Details
    • 2.2.2 QED Bioscience Major Business
    • 2.2.3 QED Bioscience Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.2.4 QED Bioscience Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 QED Bioscience Recent Developments/Updates
  • 2.3 BioChain
    • 2.3.1 BioChain Details
    • 2.3.2 BioChain Major Business
    • 2.3.3 BioChain Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.3.4 BioChain Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BioChain Recent Developments/Updates
  • 2.4 Diagnostic Automation / Cortez Diagnostics
    • 2.4.1 Diagnostic Automation / Cortez Diagnostics Details
    • 2.4.2 Diagnostic Automation / Cortez Diagnostics Major Business
    • 2.4.3 Diagnostic Automation / Cortez Diagnostics Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.4.4 Diagnostic Automation / Cortez Diagnostics Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Diagnostic Automation / Cortez Diagnostics Recent Developments/Updates
  • 2.5 MP Biomedicals
    • 2.5.1 MP Biomedicals Details
    • 2.5.2 MP Biomedicals Major Business
    • 2.5.3 MP Biomedicals Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.5.4 MP Biomedicals Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 MP Biomedicals Recent Developments/Updates
  • 2.6 Alpha Diagnostic International
    • 2.6.1 Alpha Diagnostic International Details
    • 2.6.2 Alpha Diagnostic International Major Business
    • 2.6.3 Alpha Diagnostic International Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.6.4 Alpha Diagnostic International Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Alpha Diagnostic International Recent Developments/Updates
  • 2.7 Abnova
    • 2.7.1 Abnova Details
    • 2.7.2 Abnova Major Business
    • 2.7.3 Abnova Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.7.4 Abnova Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Abnova Recent Developments/Updates
  • 2.8 CUSABIO
    • 2.8.1 CUSABIO Details
    • 2.8.2 CUSABIO Major Business
    • 2.8.3 CUSABIO Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.8.4 CUSABIO Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 CUSABIO Recent Developments/Updates
  • 2.9 Novus Biologicals
    • 2.9.1 Novus Biologicals Details
    • 2.9.2 Novus Biologicals Major Business
    • 2.9.3 Novus Biologicals Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.9.4 Novus Biologicals Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Novus Biologicals Recent Developments/Updates
  • 2.10 Hölzel Diagnostika Handels GmbH
    • 2.10.1 Hölzel Diagnostika Handels GmbH Details
    • 2.10.2 Hölzel Diagnostika Handels GmbH Major Business
    • 2.10.3 Hölzel Diagnostika Handels GmbH Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.10.4 Hölzel Diagnostika Handels GmbH Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Hölzel Diagnostika Handels GmbH Recent Developments/Updates
  • 2.11 Innovita Biological Technology
    • 2.11.1 Innovita Biological Technology Details
    • 2.11.2 Innovita Biological Technology Major Business
    • 2.11.3 Innovita Biological Technology Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Product and Services
    • 2.11.4 Innovita Biological Technology Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Innovita Biological Technology Recent Developments/Updates

3 Competitive Environment: Human Anti-Herpes Simplex Virus Type 2 ELISA Kit by Manufacturer

  • 3.1 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Revenue by Manufacturer (2021-2026)
  • 3.3 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Human Anti-Herpes Simplex Virus Type 2 ELISA Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Manufacturer Market Share in 2025
  • 3.5 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market: Overall Company Footprint Analysis
    • 3.5.1 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market: Region Footprint
    • 3.5.2 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market: Company Product Type Footprint
    • 3.5.3 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Size by Region
    • 4.1.1 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Region (2021-2032)
    • 4.1.3 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Average Price by Region (2021-2032)
  • 4.2 North America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value (2021-2032)
  • 4.3 Europe Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value (2021-2032)
  • 4.5 South America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Type (2021-2032)
  • 5.2 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Type (2021-2032)
  • 5.3 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Application (2021-2032)
  • 6.2 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Application (2021-2032)
  • 6.3 Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Type (2021-2032)
  • 7.2 North America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Application (2021-2032)
  • 7.3 North America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Size by Country
    • 7.3.1 North America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Type (2021-2032)
  • 8.2 Europe Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Application (2021-2032)
  • 8.3 Europe Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Size by Country
    • 8.3.1 Europe Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Size by Region
    • 9.3.1 Asia-Pacific Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Type (2021-2032)
  • 10.2 South America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Application (2021-2032)
  • 10.3 South America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Size by Country
    • 10.3.1 South America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Size by Country
    • 11.3.1 Middle East & Africa Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Drivers
  • 12.2 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Market Restraints
  • 12.3 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Anti-Herpes Simplex Virus Type 2 ELISA Kit and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Anti-Herpes Simplex Virus Type 2 ELISA Kit
  • 13.3 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Typical Distributors
  • 14.3 Human Anti-Herpes Simplex Virus Type 2 ELISA Kit Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Human anti-herpes simplex virus Type 2 ELISA Kit is designed for the accurate qualitative measurement of Immunoglobulin antibodies against Herpes simplex virus Type 2 in Human serum and plasma.Herpes simplex virus type 2 is a genital herpes virus that is spread through sexual contact or through any skin-on-skin contact with an open sore. It is highly contagious and can spread through secretions from the mouth or genitals. Blood tests are frequently used to detect antibodies to HSV-2 for diagnosing these infections.
    This report is a detailed and comprehensive analysis for global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Human Anti-Herpes Simplex Virus Type 2 ELISA Kit
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Human Anti-Herpes Simplex Virus Type 2 ELISA Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam plc, QED Bioscience, BioChain, Diagnostic Automation / Cortez Diagnostics, MP Biomedicals, Alpha Diagnostic International, Abnova, CUSABIO, Novus Biologicals, Hölzel Diagnostika Handels GmbH, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Human Anti-Herpes Simplex Virus Type 2 ELISA Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    IgM (Immunoglobulin M) Test
    IgG (Immunoglobulin G) Test
    Others
    Market segment by Application
    Clinic
    Hospital
    Laboratory
    Others
    Major players covered
    Abcam plc
    QED Bioscience
    BioChain
    Diagnostic Automation / Cortez Diagnostics
    MP Biomedicals
    Alpha Diagnostic International
    Abnova
    CUSABIO
    Novus Biologicals
    Hölzel Diagnostika Handels GmbH
    Innovita Biological Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Human Anti-Herpes Simplex Virus Type 2 ELISA Kit product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Human Anti-Herpes Simplex Virus Type 2 ELISA Kit, with price, sales quantity, revenue, and global market share of Human Anti-Herpes Simplex Virus Type 2 ELISA Kit from 2021 to 2026.
    Chapter 3, the Human Anti-Herpes Simplex Virus Type 2 ELISA Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Human Anti-Herpes Simplex Virus Type 2 ELISA Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Human Anti-Herpes Simplex Virus Type 2 ELISA Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Human Anti-Herpes Simplex Virus Type 2 ELISA Kit.
    Chapter 14 and 15, to describe Human Anti-Herpes Simplex Virus Type 2 ELISA Kit sales channel, distributors, customers, research findings and conclusion.

    Buy now